These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 12874518)

  • 1. Comparing dynamic parameters of tumor vascularization in nude mice revealed by magnetic resonance imaging and contrast-enhanced intermittent power Doppler sonography.
    Kiessling F; Krix M; Heilmann M; Vosseler S; Lichy M; Fink C; Farhan N; Kleinschmidt K; Schad L; Fusenig NE; Delorme S
    Invest Radiol; 2003 Aug; 38(8):516-24. PubMed ID: 12874518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sensitive noninvasive monitoring of tumor perfusion during antiangiogenic therapy by intermittent bolus-contrast power Doppler sonography.
    Krix M; Kiessling F; Vosseler S; Farhan N; Mueller MM; Bohlen P; Fusenig NE; Delorme S
    Cancer Res; 2003 Dec; 63(23):8264-70. PubMed ID: 14678984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combining dynamic contrast enhanced magnetic resonance imaging and microvessel density to assess the angiogenesis after PEI in a rabbit VX2 liver tumor model.
    Chen J; Qian T; Zhang H; Wei C; Meng F; Yin H
    Magn Reson Imaging; 2016 Feb; 34(2):177-82. PubMed ID: 26518059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamic contrast-enhanced magnetic resonance imaging rapidly indicates vessel regression in human squamous cell carcinomas grown in nude mice caused by VEGF receptor 2 blockade with DC101.
    Kiessling F; Farhan N; Lichy MP; Vosseler S; Heilmann M; Krix M; Bohlen P; Miller DW; Mueller MM; Semmler W; Fusenig NE; Delorme S
    Neoplasia; 2004; 6(3):213-23. PubMed ID: 15153333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gadopentetate dimeglumine versus ultrasmall superparamagnetic iron oxide for dynamic contrast-enhanced MR imaging of tumor angiogenesis in human colon carcinoma in mice.
    de Lussanet QG; Backes WH; Griffioen AW; van Engelshoven JM; Beets-Tan RG
    Radiology; 2003 Nov; 229(2):429-38. PubMed ID: 14595147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diffusion-weighted and dynamic contrast-enhanced MRI of prostate cancer: correlation of quantitative MR parameters with Gleason score and tumor angiogenesis.
    Oto A; Yang C; Kayhan A; Tretiakova M; Antic T; Schmid-Tannwald C; Eggener S; Karczmar GS; Stadler WM
    AJR Am J Roentgenol; 2011 Dec; 197(6):1382-90. PubMed ID: 22109293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamic T1-weighted monitoring of vascularization in human carcinoma heterotransplants by magnetic resonance imaging.
    Kiessling F; Heilmann M; Vosseler S; Lichy M; Krix M; Fink C; Kiessling I; Steinbauer H; Schad L; Fusenig NE; Delorme S
    Int J Cancer; 2003 Mar; 104(1):113-20. PubMed ID: 12532427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between estimates of tumor perfusion from microbubble contrast-enhanced sonography and dynamic contrast-enhanced magnetic resonance imaging.
    Yankeelov TE; Niermann KJ; Huamani J; Kim DW; Quarles CC; Fleischer AC; Hallahan DE; Price RR; Gore JC
    J Ultrasound Med; 2006 Apr; 25(4):487-97. PubMed ID: 16567438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamic contrast-enhanced (DCE) MRI assessment of microvascular characteristics in the murine orthotopic pancreatic cancer model.
    Wu L; Lv P; Zhang H; Fu C; Yao X; Wang C; Zeng M; Li Y; Wang X
    Magn Reson Imaging; 2015 Jul; 33(6):737-60. PubMed ID: 25169584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of intermittent-bolus contrast imaging with conventional power Doppler sonography: quantification of tumour perfusion in small animals.
    Krix M; Kiessling F; Vosseler S; Kiessling I; Le-Huu M; Fusenig NE; Delorme S
    Ultrasound Med Biol; 2003 Aug; 29(8):1093-103. PubMed ID: 12946512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early antiangiogenic activity of SU11248 evaluated in vivo by dynamic contrast-enhanced magnetic resonance imaging in an experimental model of colon carcinoma.
    Marzola P; Degrassi A; Calderan L; Farace P; Nicolato E; Crescimanno C; Sandri M; Giusti A; Pesenti E; Terron A; Sbarbati A; Osculati F
    Clin Cancer Res; 2005 Aug; 11(16):5827-32. PubMed ID: 16115922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-resolution ultrasound perfusion imaging of therapeutic angiogenesis.
    Rissanen TT; Korpisalo P; Karvinen H; Liimatainen T; Laidinen S; Gröhn OH; Ylä-Herttuala S
    JACC Cardiovasc Imaging; 2008 Jan; 1(1):83-91. PubMed ID: 19356410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intraindividual in vivo comparison of gadolinium contrast agents for pharmacokinetic analysis using dynamic contrast enhanced magnetic resonance imaging.
    Liang J; Sammet S; Yang X; Jia G; Takayama Y; Knopp MV
    Invest Radiol; 2010 May; 45(5):233-44. PubMed ID: 20351653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mural Crohn disease: correlation of dynamic contrast-enhanced MR imaging findings with angiogenesis and inflammation at histologic examination--pilot study.
    Taylor SA; Punwani S; Rodriguez-Justo M; Bainbridge A; Greenhalgh R; De Vita E; Forbes A; Cohen R; Windsor A; Obichere A; Hansmann A; Rajan J; Novelli M; Halligan S
    Radiology; 2009 May; 251(2):369-79. PubMed ID: 19276323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Solid pancreatic lesions: characterization by using timing bolus dynamic contrast-enhanced MR imaging assessment--a preliminary study.
    Kim JH; Lee JM; Park JH; Kim SC; Joo I; Han JK; Choi BI
    Radiology; 2013 Jan; 266(1):185-96. PubMed ID: 23192779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamic contrast-enhanced MR imaging kinetic parameters and molecular weight of dendritic contrast agents in tumor angiogenesis in mice.
    de Lussanet QG; Langereis S; Beets-Tan RG; van Genderen MH; Griffioen AW; van Engelshoven JM; Backes WH
    Radiology; 2005 Apr; 235(1):65-72. PubMed ID: 15731376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantifying angiogenesis in VEGF-enhanced tissue-engineered bladder constructs by dynamic contrast-enhanced MRI using contrast agents of different molecular weights.
    Cheng HL; Wallis C; Shou Z; Farhat WA
    J Magn Reson Imaging; 2007 Jan; 25(1):137-45. PubMed ID: 17139634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multi-modal magnetic resonance imaging and histology of vascular function in xenografts using macromolecular contrast agent hyperbranched polyglycerol (HPG-GdF).
    Baker JH; McPhee KC; Moosvi F; Saatchi K; Häfeli UO; Minchinton AI; Reinsberg SA
    Contrast Media Mol Imaging; 2016; 11(1):77-88. PubMed ID: 26268906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo MRI and histopathological assessment of tumor microenvironment in luminal-like and basal-like breast cancer xenografts.
    Huuse EM; Moestue SA; Lindholm EM; Bathen TF; Nalwoga H; Krüger K; Bofin A; Maelandsmo GM; Akslen LA; Engebraaten O; Gribbestad IS
    J Magn Reson Imaging; 2012 May; 35(5):1098-107. PubMed ID: 22170753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of tumor angiogenesis in a mouse PC-3 prostate cancer model using dynamic contrast-enhanced sonography.
    Lee HJ; Hwang SI; Chung JH; Jeon JJ; Choi JH; Jung HS
    J Ultrasound Med; 2012 Aug; 31(8):1223-31. PubMed ID: 22837286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.